Endoscopic Sclerotherapy for Oesophageal Varices
Anthony Arigbabu, D O Akinola
Abstract
Anthony Arigbabu, D O Akinola
Abstract
Endoscopic sclerotherapy has gained the upper hand in the treatment of bleeding oesophageal varices. The procedure is safe and the complications are transient. In this centre 25 cases were treated with sclerotherapy, using Varigloban 8% as the sclerosing agent. Bleeding was controlled in all 25 patients and varices were obliterated in 24. There were 9 recurrences at a mean of 15 months. It can be assumed that sclerotherapy eradicates oesophageal varices satisfactorily for a minimum period of one year.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Endoscopic sclerotherapy has gained the upper hand in the treatment of bleeding oesophageal varices. The procedure is safe and the complications are transient. In this centre 25 cases were treated with sclerotherapy, using Varigloban 8% as the sclerosing agent. Bleeding was controlled in all 25 patients and varices were obliterated in 24. There were 9 recurrences at a mean of 15 months. It can be assumed that sclerotherapy eradicates oesophageal varices satisfactorily for a minimum period of one year.
Key concepts: Sclerotherapy, Medicine, Varices, Varix, Surgery, Endoscopy, Esophageal varices, Portal hypertension